Newsletter | October 30, 2024

10.30.24 -- The Rise, Fall, And Eventual Rebound Of Decentralized Clinical Trials

SPONSOR

With ICH M11 expected to be adopted by the end of the year, the next Clinical Leader Live digital event will host a panel discussion on the advantages of improving and simplifying the dataflow of clinical trials but also the challenges associated with creating a connected digital dataflow, including digital health channels, that spans from protocol to data collection to CSR. Register today and join us on 10/31 at 1 pm ET (10 am PT).

DECENTRALIZED TRIALS

The Rise, Fall, And Eventual Rebound Of Decentralized Clinical Trials

First there was skepticism, then enthusiasm, and then disillusionment. DCTs have had their ups and downs. Here, we're looking ahead to the future of DCTs.

How Mobile Research Nursing Is Improving Rare Disease Clinical Trials

Learn how home visits enhance the patient experience in rare disease studies and how sponsors can use mobile research nurses to reach more rare disease patients and keep them in clinical trials longer.

End-To-End Digital Therapeutics Studies Powered By Technology

Curebase offers a variety of decentralized study models designed and tested for any type of DTx trial.

TRIAL MANAGEMENT

Want To Improve Study Startup? Work To Become More Efficient

John McAdory, VP of ClinOPs at CG Oncology, recognizes that clinical trial designs tend to be very complex, which complicates study startup. He says the key to improving this challenge is to find small ways to be more efficient throughout the process.  

What Is A Central Lab?

Central labs are pivotal in clinical research, offering a unified approach to sample processing and data management. Discover how these specialized facilities enhance trial efficiency and accuracy.

3 IRT Tactics Being Used To Streamline Supply Logistics

Shipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them.

Early Phase Trials In Australia

Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: